Single Dose Liposomal Amphotericin for Asymptomatic Cryptococcal Antigenemia — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Single Dose Liposomal Amphotericin for Asymptomatic Cryptococcal Antigenemia — Stella

Recruiting

Back to Cryptococcal Meningitis trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

Uganda

infectious Disease Institute Kampala,Uganda, Kampala

Key details

Phase

Safety & dosing / Large-scale testing

Sponsor

Makerere University

Collaborators

University of Minnesota, Gilead Sciences

Enrollment target

~356 participants

Started

June 2019

Primary completion

October 2027

Age range

15 Years and older

Last updated April 2023

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov